Beranda › Gagal Jantung › California › Mountain View
Uji klinis Gagal Jantung di Mountain View, CA
15 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ELEVATE-HFpEF Clinical Study
Menerima peserta
- Stanford University, Palo Alto · 5 mi jauhnya
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Menerima pesertaFase 3
- Research Site, Palo Alto · 5 mi jauhnya
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Menerima pesertaFase 3
- Stanford University Hospital / Stanford Health Care, Stanford · 5 mi jauhnya
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- Lucile Packard Children's Hospital ( Site 0040), Palo Alto · 5 mi jauhnya
Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM
Menerima pesertaStudi observasional
- Research Site, Palo Alto · 5 mi jauhnya
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Lucile Packard Children's Hospital, Palo Alto · 5 mi jauhnya
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Menerima pesertaStudi observasional
- Stanford, Stanford · 5 mi jauhnya
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Menerima pesertaStudi observasional
- Stanford Health Care Hospital & Clinics, Palo Alto · 5 mi jauhnya
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Menerima pesertaFase 3
- Tenax Investigational Site, Stanford · 5 mi jauhnya
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Menerima peserta
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5 mi jauhnya
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Menerima pesertaStudi observasional
- Stanford University, Palo Alto · 5 mi jauhnya
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Menerima pesertaFase 2
- Lucile Packard Children's Hospital, Palo Alto · 5 mi jauhnya
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Menerima pesertaFase 3
- Stanford University Medical Center, Stanford · 5 mi jauhnya
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Menerima peserta
- Stanford University, Stanford · 5 mi jauhnya
Identifying Markers of Exercise Training in Heart Failure
Menerima peserta
- Stanford Health Care, Stanford · 5 mi jauhnya
Uji klinis Gagal Jantung di kota lain
- New York City, NY51 studi
- Boston, MA44 studi
- Dallas, TX42 studi
- Houston, TX36 studi
- Cleveland, OH33 studi
- Chicago, IL31 studi
- Philadelphia, PA31 studi
- San Francisco, CA29 studi
- St. Louis, MO26 studi
- Durham, NC26 studi
- Kansas City, MO25 studi
- Atlanta, GA25 studi
Studi lain di Mountain View
- Kanker (semua jenis)40 studi
- Kanker Payudara25 studi
- Kanker Metastatik25 studi
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut19 studi
- Kanker Ovarium19 studi
- Gangguan Spektrum Autisme17 studi
- Kanker Paru17 studi
- Kanker Prostat15 studi
- Autisme13 studi
- Leukemia Limfoblastik Akut13 studi
- Kanker Kolorektal13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.